{
    "nctId": "NCT03144622",
    "briefTitle": "18F-FSPG PET/CT Imaging in Patients With Cancers",
    "officialTitle": "(4S)-4-(3-[18F]Fluoropropyl)-L-glutamate Radiotracer (FSPG) PET/CT for Imaging xC- Transporter Activity in Cancers",
    "overallStatus": "UNKNOWN",
    "conditions": "Pulmonary Cancer, Breast Neoplasms, Abdominal Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 120,
    "primaryOutcomeMeasure": "Staging ability of 18F-FSPG PET/CT",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients are given the opportunity to participate in the study if\n\n  1. Age \u2265 20 years old.\n  2. Confirmed diagnosis of primary cancer of the following: NSCLC, breast or abdominal cancers\n  3. ECOG performance status 0 to 2.\n  4. Life expectancy \\> 3 months.\n  5. Consent to perform additional 18F-FSPG and 18F-FDG PET prior to therapy.\n  6. Sexually active subjects agree to use condoms and/or their partners of reproductive potential to use a method of effective birth control during imaging period of 2 weeks.\n\nExclusion Criteria:\n\n* Patients with any of the following conditions will be excluded\n\n  1. Had received previous treatment (excluding neoadjuvant therapy).\n  2. Pregnant or lactating women.\n  3. Known malignancy in other organs.\n  4. Evaluated by primary care physician as unsuitable.\n  5. Known hypersensitivity to the study drug.",
    "sex": "ALL",
    "minimumAge": "20 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}